Literature DB >> 23263995

Moxa-stick suffumigation for disinfecting air in hematology and hematopoietic stem cell transplantation wards with class 100 laminar flow.

Jing-song He1, Qing Yang2, Wei-jia Huang1, Xiao-rong Hu3.   

Abstract

OBJECTIVE: To evaluate the effect of moxa-stick suffumigation in the hematology and hematopoietic stem cell transplantation (HSCT) wards with luminar flow.
METHODS: The plate exposure method was used to measure the effect of air-disinfection of moxa-stick suffumigation in hematology and HSCT wards. The yearly average qualified rates of air sampling in HSCT wards were evaluated from 2007 to 2010. To further investigate the disinfecting effect of moxa-stick suffumigation, the colony counts of common pathogens (including Staphylcoccus aureus and Pseudomonas aeruginosa) before and after moxa-stick suffumigation were compared.
RESULTS: The mean air quality rates of the HSCT wards with class 100 laminar flow were all above 90.0% (91.2%-96.2%) from 2007 to 2010. Moxa-stick suffumigation effectively decreased the presence of bacteria in the hematology ward's air (P<0.01). The most notable effect was the drastic reduction in the colony counts of Staphylococcus aureus and Pseudomonas aeruginosa on the blood plates exposed to air treated with moxa-stick suffumigation (77.1±52.9 cfu/m(2) vs 196.1±87.5 cfu/m(2), P<0.01; and 100.2±35.3 cfu/m(2) vs 371.5±35.3 cfu/m(2), P<0.01).
CONCLUSION: Moxa-stick suffumigation proved to be a reliable and effective airdisinfection method for hematology and HSCT wards, and hence, it should be employed extensively.

Entities:  

Keywords:  bacterial culture; hematopathy; moxa-stick suffumigation

Mesh:

Substances:

Year:  2012        PMID: 23263995     DOI: 10.1007/s11655-012-1181-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  2 in total

1.  Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase.

Authors:  Y Luo; X-Y Lai; Y-M Tan; J-M Shi; Y-M Zhao; X-Y Han; G-F Zheng; X-L Zhu; J Sun; Y-L Zheng; G-Q Wu; J-S He; S-Y Chen; A-Y Jin; W-Z Xie; X-J Ye; Z Cai; M-F Lin; H Huang
Journal:  Leukemia       Date:  2009-02-05       Impact factor: 11.528

2.  The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

Authors:  G Q Wu; Y M Zhao; X Y Lai; Y Luo; Y M Tan; J M Shi; L Li; W Y Zheng; J Zhang; X R Hu; A Y Jin; J S He; W Z Xie; X J Ye; Z Cai; M F Lin; H Huang
Journal:  Bone Marrow Transplant       Date:  2010-02-22       Impact factor: 5.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.